Thrombotic Ischaemic Stroke & Endovascular Thrombectomy

The curriculum asks for knowledge of "anaesthesia for... interventional radiology procedures for cerebral aneurysms and stroke thrombectomy"

In a CRQ on mechanical thrombectomy (March 2026) candidates dropped marks particularly on blood pressure targets in the post-operative period.

Thrombotic ischaemic stroke was an SAQ in March 2019 (63% pass rate) with knowledge of specific neurocritical care interventions lacking.

Resources


  • Stroke is the third most common cause of death and the leading cause of disability in the developed world; two-thirds of patients leave hospital with a disability
  • Incidence in younger adults is rising

  • Acute ischaemic stroke accounts for 85% of all cases
    • A critical reduction in blood flow results in ischaemia and cell death within the ischaemic core
    • The surrounding tissue (penumbra) receives minimal blood flow via collaterals; it is salvageable for several hours and therefore prompt restoration of blood flow is crucial
  • The remaining 15% is haemorrhagic e.g. intra-cerebral or sub-arachnoid haemorrhage

  • Historically the only option for reperfusion was IV thrombolysis (IVT)
    • Only 10 - 40% of patients with large vessel occlusion (LVO) and anterior circulation stroke will achieve good clinical outcome following IV thrombolysis
    • Endovascular thrombectomy (EVT) provides a ~20% increase in functional independence compared with IV thrombolysis alone and is now the standard of care for LVO
    • Despite being suitable for 15 - 20% of ischaemic strokes, uptake in the UK remains low (<1 - 7% depending on region)

National Institute of Health Stroke Scale (NIHSS) Score

  • Measures severity of stroke by scoring: level of consciousness, vision, sensation, movement, speech, language
Score Grade
0 No stroke
5-15 Moderate stroke
16-20 Moderate-severe stroke
21-42 Severe stroke

Modified Rankin Scale (mRS)

  • Measures degree of disability; the most commonly used outcome measure in stroke trials (usually at 90 days)
  • mRS 0 - 2 is considered 'functional independence' i.e. a good outcome
Grade Description
0 No symptoms
1 No significant disability
2 Slight disability; independent but unable to carry out all previous activities
3 Moderate disability; walks independently but requires help with ADLs
4 Moderate-severe disability; not independent with ADLs
5 Severe disability; full-time nursing care
6 Death


Evidence base

  • Mechanical/endovascular thrombectomy aims to provide rapid recanalisation of occluded large cerebral arteries
  • The landmark MR CLEAN trial (2015) demonstrated improved 90-day functional independence with EVT + IVT compared with IVT alone (33% vs 19%)
  • Multiple contemporaneous trials had similar findings; pooled data demonstrates the NNT to reduce mRS score by one level is 2.6

  • Extended time window
    • The DEFUSE-3 (2018) and DAWN (2018) trials extended the window for EVT up to 24hrs in patients with favourable imaging i.e. a small ischaemic core with a large salvageable penumbra
    • Beyond 24hrs EVT is only considered on a case-by-case basis

  • Combination with IV thrombolysis
    • EVT without IVT has not been shown to be non-inferior and longer-term data favour EVT + IVT, so eligible patients should still receive thrombolysis

  • Other territories:
    • Posterior circulation: growing evidence of benefit in basilar artery occlusion albeit with increased rate of symptomatic intracranial haemorrhage (~5%)
    • Medium or distal vessel occlusion: no improvement in function outcome vs. medical therapy alone, but doubles risk of symptomatic intracranial haemorrhage

    Eligibility criteria for EVT
    Confirmed intracranial large vessel occlusion, typically internal carotid or MCA segments M1 or M2 (anterior), or basilar (posterior)
    Disabling neurological deficit: NIHSS >6 for anterior circulation, NIHSS >10 for posterior circulation
    Presentation within 6hrs of symptom onset, or 6 - 24hrs (including wake-up stroke) if favourable imaging
    No previous disability i.e. pre-stroke mRS 0 - 1
    IV thrombolysis given first if eligible, but should not delay transfer for EVT

  • The benefit of EVT diminishes with increasing time interval between onset and intervention

Pre-hospital

  • Increased public awareness of symptoms through education e.g. 'Act FAST' campaign, although time from symptom onset to calling emergency services remains long
  • Pre-hospital triage systems and regional stroke networks
    • In England these are Integrated Stroke Delivery Networks using a hub-and-spoke model
    • Enable prompt patient assessment and stabilisation
    • Patients are delivered to units best able to provide appropriate specialist care
    • Hospitals should be pre-alerted to allow mobilisation of resources in time for arrival
  • Innovations include telemedicine (video assessment by a stroke physician from the ambulance) and mobile stroke units with on-board CT, which shorten onset-to-thrombolysis time by ~30mins

In-hospital

  • Initial emergency department care should include:
    • Rapid assessment to establish time since stroke onset (or last seen well)
    • Neurological evaluation with NIHSS
    • Baseline investigations, which should not delay imaging or thrombolysis:
      • Bloods: FBC, U&E, glucose, clotting, troponin (prognostication)
      • ECG
    • Imaging:
      • Non-contrast CT within 20mins of arrival to exclude intracranial haemorrhage, tumour or other contraindication to thrombolysis
      • CT angiography to identify the site of vascular occlusion
      • CT perfusion to evaluate the volume of ischaemic core and penumbra, helping select patients who will benefit from EVT
      • AI software is increasingly used to detect ischaemic changes and speed up decision making

  • Thrombolysis should be administered ASAP (ideally in the CT suite) in those for whom it is appropriate, and within 4.5hrs e.g. alteplase 0.9mg/kg or tenecteplase

Interval Suggested maximum time
Door to review by stroke physician ≤10mins
Door to CT scan ≤20mins
Door to thrombolysis needle ≤45mins
Door to groin puncture ≤75mins
Door to first thrombectomy device ≤90mins

Transfer to EVT centre

  • The decision to proceed is made jointly by the stroke physician and neuroradiologist; the patient is then urgently transferred to the nearest comprehensive stroke centre
  • 'Drip and ship': local (spoke) hospitals initiate triage, imaging and thrombolysis then refer to the hub for EVT
  • 'Mothership': local hospitals are bypassed in favour of direct transfer to the comprehensive stroke centre
    • A recent RCT found no difference in 90-day outcomes between the two models
    • Patients who turned out to have intracerebral haemorrhage had worse outcomes if the local hospital was bypassed; rapid access to EVT must be balanced against the needs of patients with ICH or stroke mimics

Performance of EVT

  • Typically femoral artery access; less commonly radial and rarely carotid
  • A microcatheter and guidewire are navigated to the clot under real-time fluoroscopy
  • Clot retrieval is via:
    • Stent retrievers: mesh-like devices opened within the occlusion to capture the clot, which is then withdrawn
    • Aspiration catheters: suction is used to aspirate the clot directly
  • Some interventionalists will use heparin to minimise risk of catheter-related embolism
  • If a stent is left in situ (e.g. for a co-existing fixed carotid stenosis), dual antiplatelet therapy is required for 3 - 6 months
  • Reperfusion is assessed angiographically using the modified Thrombolysis in Cerebral Infarction (mTICI) grading system
    • Scale of 0 (no perfusion) to 3 (full perfusion); grade 2 is subdivided into 2a and 2b
    • Successful reperfusion is mTICI 2b/3

Perioperative Management of the Patient Undergoing Endovascular Thrombectomy


  • Irrespective of technique, the two most important anaesthetic goals are minimising time delay and haemodynamic control

Assessment

  • On arrival in the neuroradiology suite the patient is reassessed by the anaesthetist, stroke physician and neuroradiologist to decide:
    • Whether further imaging is needed
    • The most appropriate anaesthetic technique, based on comorbidities, conscious level and agitation
    • Any anticipated technical difficulties
  • Patients are often elderly with multiple comorbidities and may be unable to give a history
  • Obtain handover from the ED team, stroke team or paramedics
    • AMPLE history and airway assessment
    • Review available baseline investigations (FBC, clotting, glucose, ECG)
    • There is rarely time to request further tests, and these should not delay the procedure
  • Continue thrombolysis infusion if running

Preparation

  • Interventional suites are often remote from theatres; protocols and trained staff should be in place
  • Intubation trolley and suction
  • Induction drugs and emergency drugs (ephedrine, metaraminol, atropine, glycopyrronium)
  • IV fluids and a metaraminol infusion attached via long extension lines

  • Historical concern about the effect of GA on outcome persists
    • Often this concern is founded on the results of retrospective reviews of methodologically imperfect observational studies
    • These suffered from selection bias (GA patients had more severe strokes) and recorded few details of BP or ventilation

  • Small single-centre RCTs suggested GA was at least as good as conscious sedation, with a trend towards better outcomes
  • Larger multicentre RCTs have produced mixed results:
    • The GASS trial (2022) found GA non-inferior for functional outcome and superior for reperfusion (85% vs 75%), using a strict GA protocol with tight BP control
    • Subsequent, more pragmatic trials have shown either no difference or a benefit of GA for reperfusion and functional independence

  • The most recent meta-analysis (8 RCTs, 1300 patients) shows higher recanalisation rates with GA, but no difference in functional recovery or 3-month mortality
  • Posterior circulation stroke: no difference in functional outcome, but almost 30% of sedation patients crossed over to GA; a default to GA may be more appropriate in this group

  • Current recommendations are for an individualised approach based on patient risk factors, procedural factors and other clinical characteristics
  • In practice choice is largely determined by institutional protocols, logistics and operator preference; GA is the default in many UK centres

General anaesthesia

Advantages Disadvantages
Airway protection with ETT; ↓ aspiration risk Hypotension (especially at induction) exacerbating ischaemic injury
Control of ventilation & ETCO2 Inability to monitor neurological status intra-procedurally
Patient immobility reduces procedural injury risk Longer door-to-groin puncture time (offset by a shorter groin-to-reperfusion time)
↑ recanalisation rates ↑ risk of POD and POCD
↓ technical failure rate ↑ rate of pneumonia in some studies, but no effect on morbidity/mortality
Avoids emergency conversion from sedation, which is associated with worse outcomes

Conscious sedation

Advantages Disadvantages
Shorter door-to-groin puncture time Patient discomfort or distress
Less haemodynamic instability Movement may increase procedural complications
Continuous neurological assessment Risk of aspiration, hypoxia, airway obstruction and hypercapnia
Option where GA is contraindicated by severe comorbidity Conversion to GA (3 - 30%) as an unplanned emergency


Monitoring and access

  • AAGBI monitoring; NIBP on a 3-min cycle is sufficient in most patients
  • Invasive arterial monitoring if haemodynamic instability is anticipated or NIBP is unreliable (e.g. high BMI, AF)
    • Should not delay the procedure; the femoral sheath placed by the neuroradiologist can be transduced
  • Processed EEG causes minimal interference with fluoroscopy and may be beneficial in this cohort
  • Bladder distension may cause failure of sedation, but catheterisation should not delay groin puncture; take care after thrombolysis to ensure atraumatic insertion

Practical considerations

  • Neuroradiologists operate from the patient's right side; site IV access and arterial lines in the left arm where possible
  • Use long extensions on infusions and fluid lines due to limited patient access
  • Keep lines, cables and ventilator tubing off the floor to avoid trip hazards and interference with the C-arm
  • Radiation safety: maintain a safe distance from the radiation source

Local anaesthesia ± conscious sedation

  • Local anaesthesia alone is possible in conscious, cooperative patients who can lie flat
    • Small fentanyl boluses (12.5 - 25mcg) may be required for groin puncture, contrast injection and clot retrieval
  • Sedation should be cautious given limited access, communication difficulties and possible neurological deterioration
  • Short-acting agents with analgesic properties are recommended
  • Examples:
    • Remifentanil TCI ± propofol
    • Dexmedetomidine
    • Midazolam with fentanyl, although the sedative effect is unpredictable and difficult to titrate

General anaesthesia

  • GA is recommended in patients for whom conscious sedation is inappropriate or where conversion to GA may be suspected:
    • Agitation or reduced GCS
    • Nausea/vomiting or aspiration risk
    • Airway compromise or already intubated
    • Complicated anatomy e.g. tortuous or calcified vessels, distal occlusions
    • Large, dominant hemisphere strokes
    • Posterior circulation stroke

  • Induction is usually best performed on the patient's bed/ambulance trolley
  • Start a metaraminol infusion just before induction and be ready to give boluses
  • Example induction: fentanyl 1 - 2mcg/kg, propofol 1 - 2mg/kg, rocuronium 1.2mg/kg; RSI if non-fasted
  • Maintenance with sevoflurane or propofol ± remifentanil TCI
    • Retrospective data suggest an association between propofol TIVA and better functional outcome, but this requires confirmation in RCTs
  • Antiemesis: dexamethasone and ondansetron if not contraindicated

Physiological targets

  • Maintenance of normal physiology during this vulnerable period of cerebral ischaemia is important for patient outcome

  • Blood pressure
    • Consensus guidelines recommend an SBP target of 140 - 180mmHg to maintain collateral perfusion
    • A MAP drop of ≥10% from baseline is associated with poorer outcomes; if baseline SBP is <140mmHg, aim to stay within 10% of baseline
    • Targets may need adjusting after recanalisation following discussion with the neuroradiologist and neurologist
    • Balance hyper- and hypo-tension with:
      • Metaraminol: 0.5 - 1mg boluses or infusion (e.g. 10mg in 20ml, 0.5mg/ml) starting at 5 - 10ml/hr
      • Labetalol: 5 - 10mg boluses if rapid control needed, or infusion (neat 5mg/ml in 20ml syringe) starting at 10ml/hr
    • Be wary of GTN patches or nimodipine which may have been used by Stroke or IR teams to aid vascular access

  • Oxygenation: maintain SpO2 >92 - 94%, with no role for hyperoxia
  • Ventilation: maintain PaCO2 4.5 - 5.0kPa
    • Avoid uncontrolled hypercapnia (e.g. deep sedation in a spontaneously breathing patient)
    • Vasodilatation in healthy brain diverts flow away from the already-maximally-dilated ischaemic territory ('cerebral steal' or reversed Robin Hood phenomenon)
  • Normoglycaemia: 7.8 - 10mmol/L; hyperglycaemia is common and predicts poor outcome
  • Normothermia: hyperthermia increases metabolic demand; there is no role for cooling

Emergence

  • Early cessation of sedation and extubation is recommended to allow neurological assessment
  • Extubate on the patient's bed in reverse Trendelenburg; avoid flexing the hips due to risk of femoral access site bleeding
  • Careful suctioning after thrombolysis, as any mucosal abrasion can cause significant airway bleeding

Haemodynamics

  • Ongoing neurological and haemodynamic monitoring is required
  • After reperfusion therapy (thrombolysis or EVT), BP should be maintained ≤180/105mmHg
    • The optimal post-procedure target is unknown; a peak SBP >158mmHg is associated with worse outcomes, but so is aggressive lowering to <120mmHg
    • Agents such as labetalol, nicardipine or sodium nitroprusside may be required
    • Restarting antihypertensive therapy within 48 - 72hrs is safe but not associated with better outcomes

Analgesia

  • Pain is usually minor; headache or pain at groin puncture site
  • Paracetamol is safe and usually adequate
  • NSAIDs should be avoided owing to the increased risk of bleeding at the groin puncture site, intracranially or via haemorrhagic transformation
  • Opioids must be used with caution owing to:
    • Their ability to cloud neuromonitoring post-operatively
    • Hypoventilation-induced hypercapnia affecting CBF while autoregulation is impaired
  • Prescribe antiemetics

Homeostasis

  • Normothermia
  • Normoglycaemia
  • Neutral fluid balance
  • Cardiac monitoring for 24hrs to screen for AF; electrolyte control to reduce risk of AF
  • Consider urinary catheterisation to avoid emergence agitation from a full bladder
  • Avoid NG tube if recent thrombolysis
  • NBM pending SALT assessment
  • Mechanical-only VTE prophylaxis initially
  • Antiplatelets after 24hrs if thrombolysed

Disposition

  • Institutional variation; sedation cases usually go directly to the hyperacute stroke unit (HASU), GA cases via recovery
  • Critical care if intubated on arrival, low pre-procedure GCS or complications

  • Incidence of complications can be reduced if EVT is only performed in units with high case volume (>200/yr) and regular assessment/audit of outcomes

Haemorrhagic

  • Intracranial haemorrhage (5 - 10%)
    • Usually haemorrhagic transformation of the infarct; risk is higher with large core infarcts
    • May also be device-related
    • Requires reversal of heparin with protamine
  • Vessel perforation (rare but serious)
    • Causes SAH; often seen as sudden contrast extravasation on fluoroscopy
    • Lower BP promptly and consider reversal of anticoagulation
  • Puncture-site haemorrhage
  • Retroperitoneal haemorrhage (rare)

Device-associated

  • Embolic: clot fragmentation can cause emboli to new territories, which may need retrieval
  • Vessel dissection: may reduce flow or occlude the vessel; treated with stenting, anticoagulation or DAPT
  • Vasospasm: often resolves with temporary catheter withdrawal; caution with nimodipine due to hypotension
  • No-reflow phenomenon: microvascular injury prevents reperfusion despite clot removal; intra-arterial vasodilators may be used and arterial pressure should be maintained to support collateral flow

Other

  • Orolingual angioedema (up to 5% after alteplase, especially with ACE inhibitors)
    • Usually mild and transient; intubate early if the airway is threatened (awake fibreoptic intubation may be needed)
    • Treatments include icatibant (bradykinin receptor antagonist) or C1-esterase inhibitor
  • Contrast reactions including anaphylaxis (<1%)
  • Contrast nephropathy
  • Puncture-site haematoma, infection or pseudoaneurysm; limb ischaemia (rare)
  • Anaesthetic: respiratory depression, airway obstruction, aspiration, haemodynamic instability, patient movement